NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

Ned Sharpless’s portrait unveiled at FNIH ceremony

Former NCI director Norman “Ned” Sharpless had his portrait unveiled at a ceremony hosted by the Foundation for the National Institutes of Health on the main NIH campus in Bethesda.

July 10, 2026

Vol.52 No.27

Clinical Roundup

Should lowest-risk prostate cancer still be called “cancer”? UCLA-led study suggests changing the name could save lives

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer “cancer” does more harm than good. A UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leading to significantly fewer deaths from aggressive prostate cancer.

July 10, 2026

Vol.52 No.27

Cancer Policy

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Democratic leaders of the House Committee on Energy and Commerce are urging NIH Director Jay Bhattacharya to voice objections to a proposed rule from the Office of Management and Budget that would give the administration unprecedented political control over government-funded science.

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

FDA has issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for some cancer pharmaceuticals.

June 18, 2026

Vol.52 No.24

By Claire Marie Porter

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

The White House Office of Management and Budget has published a “Regulation for Federal Financial Assistance,” a proposed rule that seeks to fundamentally redraw the ground rules for all federally funded research. On the other side are America’s scientists who aren’t just crying foul—they are readying for a political fight.

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

On June 9, the House Appropriations Committee passed its version of the fiscal year 2027 spending bill for Labor, Health and Human Services, and Education.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

YOU MAY BE INTERESTED IN

Ned Sharpless’s portrait unveiled at FNIH ceremony

Should lowest-risk prostate cancer still be called “cancer”? UCLA-led study suggests changing the name could save lives

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

Renew today!

Subscriber content

Never miss an issue!

Login

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

YOU MAY BE INTERESTED IN

Ned Sharpless’s portrait unveiled at FNIH ceremony

Should lowest-risk prostate cancer still be called “cancer”? UCLA-led study suggests changing the name could save lives

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

FDA clears a way for dramatic reduction in animal toxicology studies in cancer

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

Never miss an issue!

Login

Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”